BRAIN and DECHEMA cooperate in the biotechnological production of perillic acid
BRAIN AG and the DECHEMA Society for Chemical Engineering and Biotechnology in Frankfurt have announced a collaboration in the biotechnological production of perillic acid.
This patented natural monoterpene is owned by BRAIN and will be used in a wide range of applications as a bioactive compound in cosmetic products.
The cooperation is aimed at advancing further development of an integrated bio-process for efficient microbial (+)-perillic acid synthesis from the cheap precursor (+) limonene, developed by PD Dr. Jens Schrader and his team at DECHEMA. The compound (+) limonene is extracted in large quantities from orange peel.
By combining the competencies in strain and process optimisation as well as Scale-Up at the Karl-Winnacker-Institute of the DECHEMA, with the microbiological and molecular biological methods of BRAIN, this project is aimed at developing an integrated bio-process for effective technical production.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
2,4-Dinitrophenol
Filming bacterial life in multicolor as a new diagnostic and antibiotic discovery tool - Multicolored probes target cell wall synthesis in the arms race with bacteria
Scripps Research Scientists Identify Blood Component that Turns Bacteria Virulent - Findings May Provide Basis for New Drug Development

Merck Completes Acquisition of Exelead and Plans to Invest More Than € 500 Million in Technology Scale-Up - Company now offers comprehensive end-to-end services across mRNA value chain

A new, highly sensitive chemical sensor uses protein nanowires - UMass Amherst team introduces high-performing 'green' electronic sensor

Revolution in blood donation? Enzymes open new path to universal donor blood - Researchers have discovered enzymes that remove hindrances that stood in the way of developing universal donor blood

Mobile phone use may affect semen quality - Is 4G less harmful than 2G?

How to make it easier to turn plant waste into biofuels - Innovative process to rapidly dissolve plant fibers
